Found 4 matching trials
Study of ALXN1850 in Participants With Hypophosphatasia (HPP)
PHASE1This is an open-label, dose-escalating study to assess safety, tolerability...
Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa
PHASE3The primary objective of this study is to assess the efficacy of ALXN1850 v...
Status
Active Not Recruiting
Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP
PHASE3The primary purpose of this study is to evaluate the efficacy of ALXN1850 v...
Status
Active Not Recruiting
Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa
PHASE3The primary purpose of this study is to assess the safety and tolerability ...
Status
Active Not Recruiting